antibiotic R&D

I have written two blogs relevant to today’s discussion.  In one, I decry the absence of guidelines from professional soc

# Reprinted with permission from Dr. Shlaes' blog. The original post can be found here.  

The key problem for many struggling with the treatment of resistant infections and a paltry pipeline of new antibiotics has been the lack of a return on investment for companies trying to discover and develop new antibiotics.  In hospi

This is antibiotic awareness week. To mark this week, there has been a great deal of talk and the publication of several important papers and workshops on antibiotics and resistance.

American Council advisor, and infectious disease expert Dr. David Shlaes has been writing a blog called "Antibiotics—the Perfect Storm" since 2009.

We at ACSH have been writing about the dire situation we face because

We at ACSH are fortunate to have amongst our erudite Advisors

Yesterday, we took Zeke Emanuel s and his

There is